当前位置: 首页 >> 检索结果
2090. Effect of Corticosteroids on Mortality and Clinical Cure in Community-Acquired Pneumonia: A Systematic Review, Meta-analysis, and Meta-regression of Randomized Control Trials.
作者: Naveed Saleem.;Adarsh Kulkarni.;Timothy Arthur Chandos Snow.;Gareth Ambler.;Mervyn Singer.;Nishkantha Arulkumaran.
来源: Chest. 2023年163卷3期484-497页
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality. Corticosteroids may be a beneficial adjunct in the treatment of bacterial pneumonia.
2091. Gastroesophageal Reflux Disease Increases Susceptibility to Nontuberculous Mycobacterial Pulmonary Disease.
作者: Youlim Kim.;Jai Hoon Yoon.;Jiin Ryu.;Bumhee Yang.;Sung Jun Chung.;Hyung Koo Kang.;Dong Won Park.;Tai Sun Park.;Ji-Yong Moon.;Tae-Hyung Kim.;Sang-Heon Kim.;Jang Won Sohn.;Ho Joo Yoon.;Hyun Lee.;Hayoung Choi.
来源: Chest. 2023年163卷2期270-280页
Gastroesophageal reflux disease (GERD) is a common comorbidity of nontuberculous mycobacteria (NTM) pulmonary disease (PD). Although GERD is associated with more symptoms and severe disease in patients with NTM PD, whether GERD is associated with an increased risk of NTM PD developing is unknown.
2092. Diagnostic Accuracy of a Convolutional Neural Network Assessment of Solitary Pulmonary Nodules Compared With PET With CT Imaging and Dynamic Contrast-Enhanced CT Imaging Using Unenhanced and Contrast-Enhanced CT Imaging.
作者: Jonathan R Weir-McCall.;Elise Debruyn.;Scott Harris.;Nagmi R Qureshi.;Robert C Rintoul.;Fergus V Gleeson.;Fiona J Gilbert.; .
来源: Chest. 2023年163卷2期444-454页
Solitary pulmonary nodules (SPNs) measuring 8 to 30 mm in diameter require further workup to determine the likelihood of malignancy.
2093. Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity.
作者: Mona Alotaibi.;Junzhe Shao.;Michael W Pauciulo.;William C Nichols.;Anna R Hemnes.;Atul Malhotra.;Nick H Kim.;Jason X-J Yuan.;Timothy Fernandes.;Kim M Kerr.;Laith Alshawabkeh.;Ankit A Desai.;Andreea M Bujor.;Robert Lafyatis.;Jeramie D Watrous.;Tao Long.;Susan Cheng.;Stephen Y Chan.;Mohit Jain.
来源: Chest. 2023年163卷1期204-215页
The prognosis and therapeutic responses are worse for pulmonary arterial hypertension associated with systemic sclerosis (SSc-PAH) compared with idiopathic pulmonary arterial hypertension (IPAH). This discrepancy could be driven by divergence in underlying metabolic determinants of disease.
2094. Helmet vs Facemask CPAP in COVID-19 Respiratory Failure: A Prospective Cohort Study.
作者: Nicolás Colaianni-Alfonso.;Guillermo Cesar Montiel.;María Laura Vega.;Guido Mazzinari.;José Miguel Alonso-Íñigo.;Domenico Luca Grieco.
来源: Chest. 2023年163卷2期341-344页 2095. A 30-Minute Spontaneous Breathing Trial Misses Many Children Who Go On to Fail a 120-Minute Spontaneous Breathing Trial.
作者: Kelby E Knox.;Justin C Hotz.;Christopher J L Newth.;Michael C K Khoo.;Robinder G Khemani.
来源: Chest. 2023年163卷1期115-127页
The optimal length of spontaneous breathing trials (SBTs) in children is unknown.
2096. Long-term Azithromycin in Children With Bronchiectasis Unrelated to Cystic Fibrosis: Treatment Effects Over Time.
作者: Don Vicendese.;Stephanie Yerkovich.;Keith Grimwood.;Patricia C Valery.;Catherine A Byrnes.;Peter S Morris.;Shyamali C Dharmage.;Anne B Chang.
来源: Chest. 2023年163卷1期52-63页
Following evidence from randomized controlled trials, patients with bronchiectasis unrelated to cystic fibrosis receive long-term azithromycin to reduce acute respiratory exacerbations. However, the period when azithromycin is effective and which patients are likely to most benefit remain unknown.
2097. Refining the Lung Allocation Score Models Fails to Improve Discrimination Performance.
作者: Jarrod E Dalton.;Carli J Lehr.;Paul R Gunsalus.;Lyla Mourany.;Maryam Valapour.
来源: Chest. 2023年163卷1期152-163页
As broader geographic sharing is implemented in lung transplant allocation through the Composite Allocation Score (CAS) system, models predicting waitlist and posttransplant (PT) survival will become more important in determining access to organs.
2099. "No Escalation of Treatment" Designations: A Multi-institutional Exploratory Qualitative Study.
作者: Jason N Batten.;Jacob A Blythe.;Sarah E Wieten.;Elizabeth Dzeng.;Katherine E Kruse.;Miriam P Cotler.;Karin Porter-Williamson.;Joshua B Kayser.;Stephanie M Harman.;David Magnus.
来源: Chest. 2023年163卷1期192-201页
No Escalation of Treatment (NoET) designations are used in ICUs internationally to limit treatment for critically ill patients. However, they are the subject of debate in the literature and have not been qualitatively studied.
2100. Temporal Trends and Variation in Bronchoscopy Use for Acute Respiratory Failure in the United States.
作者: Max T Wayne.;Thomas S Valley.;Douglas A Arenberg.;Jose De Cardenas.;Hallie C Prescott.
来源: Chest. 2023年163卷1期128-138页
National data on bronchoscopy for the evaluation of acute respiratory failure are lacking, and the limited available data suggest wide variation in use.
|